Reference
Namba M, et al. A case of EML4-ALK-positive lung adenocarcinoma that was successfully treated with alectinib after the discontinuation of crizotinib due to drug-induced edema and stasis dermatitis. . Haigan / Japanese Journal of Lung Cancer 55: 212-217, No. 4, 20 Aug 2015 - Japan
Rights and permissions
About this article
Cite this article
Alectinib/crizotinib. Reactions Weekly 1574, 20 (2015). https://doi.org/10.1007/s40278-015-1476-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-1476-y